Matthew Seftel Selected Research

Matthew Seftel Research Topics

6	Leukemia 01/2021 - 12/2013
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2016
5	Neoplasms (Cancer) 01/2018 - 08/2013
4	Hematologic Neoplasms (Hematological Malignancy) 12/2021 - 01/2015
4	Lymphoma (Lymphomas) 08/2015 - 08/2008
3	Hodgkin Disease (Hodgkin's Disease) 08/2022 - 08/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 12/2013
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2015 - 08/2012
3	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2015 - 11/2014
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 03/2014
2	Aplastic Anemia (Anemia, Hypoplastic) 05/2016 - 11/2014
2	Infections 01/2015 - 08/2013
1	COVID-19 09/2022
1	Cytomegalovirus Infections (Inclusion Disease) 12/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2020
1	monosomy Chromosome 7 01/2020
1	Pathologic Complete Response 01/2020
1	Philadelphia Chromosome 01/2018
1	Polycythemia Vera 11/2015
1	Essential Thrombocythemia 11/2015
1	Primary Myelofibrosis (Myelosclerosis) 11/2015
1	Mucormycosis 01/2015
1	Invasive Fungal Infections 01/2015
1	Aspergillosis 01/2015
1	Febrile Neutropenia 08/2013
1	Pain (Aches) 01/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2012
1	Multiple Myeloma 03/2010

3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 12/2013
2	AntigensIBA 01/2018 - 12/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2014 - 12/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2013 - 01/2013
1	Rituximab (Mabthera)FDA Link 01/2018
1	Chimeric Antigen ReceptorsIBA 12/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2016
1	Dacarbazine (DIC)FDA LinkGeneric 10/2016
1	Vincristine (Oncovin)FDA LinkGeneric 10/2016
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2016
1	Prednisone (Sone)FDA LinkGeneric 10/2016
1	Procarbazine (Matulane)FDA Link 10/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2016
1	Etoposide (VP 16)FDA LinkGeneric 10/2016
1	HLA-DR Antigens (HLA-DR)IBA 03/2016
1	Janus KinasesIBA 11/2015
1	Guanosine Diphosphate (GDP)IBA 08/2015
1	Methotrexate (Mexate)FDA LinkGeneric 05/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	dectin 1IBA 01/2015
1	Alemtuzumab (Campath)FDA Link 11/2014
1	Busulfan (Busulfex)FDA Link 12/2013
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 08/2013
1	Tyrosine Kinase InhibitorsIBA 04/2012

14	Cell Transplantation 09/2022 - 03/2010
12	Therapeutics 08/2022 - 08/2007
7	Hematopoietic Stem Cell Transplantation 01/2021 - 08/2007
5	Transplantation 12/2021 - 08/2012
4	Drug Therapy (Chemotherapy) 01/2018 - 01/2015
4	Homologous Transplantation 01/2016 - 08/2007
3	Stem Cell Transplantation 08/2015 - 08/2008
1	Combination Drug Therapy (Combination Chemotherapy) 10/2016
1	Autologous Transplantation 08/2012